MRD Testing: Primary Endpoint For Drug Development

C. Ola Landgren, M.D. Chief of the Myeloma Service in the Division of Hematologic Oncology at Memorial Sloan Kettering Cancer Center Discusses MRD Testing: Primary Endpoint For Drug Development at Lym... Author: imedex Added: 12/31/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts